Longwood Fund Announces Longwood Healthcare Leaders, a Webconference for Industry Leaders, on Sept. 21-22, 2022
BOSTON, September 8, 2022 (Newswire.com) - Longwood Fund, an early-stage life science venture firm focused on company creation, will convene several hundred top biotech and pharmaceutical leaders at its Fall Longwood Healthcare Leaders meeting, hosted virtually via webconference, on Sept. 21-22, 2022.
The meeting focuses on a broad spectrum of topics affecting the biopharma ecosystem. Biopharma CEOs and C-suite executives, heads of R&D, therapeutic area heads, top academics, and healthcare investors will join off-the-record discussions of ideas, strategies and insights intended to help the community translate groundbreaking discoveries into medicines to help patients.
Hosted by Longwood Fund, industry leaders will speak in moderated keynotes, fireside chats, and discussion panels: FDA CBER Director Peter Marks, Pfizer CSO & President of WRDM Mikael Dolsten, Moderna scientific founder and MIT Institute Professor Bob Langer, Massachusetts Senator Ed Markey, Foundation for the NIH CEO Julie Gerberding, Genentech head of research and early development Aviv Regev, Regeneron President & CSO George Yancopoulos, Amgen head of R&D Dave Reese, Editas CEO Gilmore O'Neill, Vir CEO George Scangos, Voyager CEO Al Sandrock, Sage CEO Barry Greene, Sanofi NA R&D head Raquel Mura, Bayer head of pRED Phil Larsen, Roche head of pRED Hans Clevers, Broad MIT Institute Member Sangeeta Bhatia, Biogen head of R&D Priya Singhal, Mass General Brigham CEO Anne Klibanski, among others.
Topics discussed include big biopharma R&D collaboration, big biopharma pipeline sourcing, accelerating the path to patient care, harnessing biomedical innovation, clinical trial efficiency, launching and building biotech companies, drug approvals, drug discovery sciences, raising and managing capital, among others.
Profits from the meeting benefit charities including Ukrainian humanitarian efforts, Life Science Cares, The Boston Foundation, Harvard Medical School, MIT, and others. Registered participants are invited to join a cocktail reception at The Country Club in Brookline, MA, with Massachusetts AG and leading MA gubernatorial candidate Maura Healey. To learn more, visit www.longwoodhealthcareleaders.com.
Longwood Healthcare Leaders
Longwood Healthcare Leaders meetings bring together leading biotech and pharma CEOs, heads of R&D, top academics, and healthcare investors for off-the-record discussions to drive transparency and collaboration to accelerate the translation of discoveries into medicines to help patients.
Longwood Fund
Longwood Fund is a venture capital firm dedicated to creating and investing in novel healthcare companies that develop important treatments to help patients while targeting significant value for investors. The Longwood team has a long history of successfully launching and building important life science companies while providing operational leadership and strategic guidance. Collectively, the Partners at Longwood Fund have co-founded 25 companies with over 20 launched or marketed drugs and therapies, as well as over two dozen clinical-stage assets, all focused on helping patients in need. Companies founded by Longwood Fund, or its principals prior to the founding of the Firm, as lead investor and CEO/CBO include Vertex, Acceleron, Momenta, Alnylam, Sirtris, Vor, TScan, Pyxis Oncology, Immunitas, Be Biopharma, ImmuneID, Tome Bio, Photys, Carbon Biosciences, and DEM Bio. To learn more, visit www.longwoodfund.com.
Source: Longwood Fund
